| Also known as |
5-alpha-hydroxy-laxogenin, Laxogenin |
| Blood pressure |
No significant impact on blood pressure reported |
| Chemical name |
(25R)-3ОІ-Hydroxy-5О±-spirostan-6-one |
| Dosage (medical) |
Not medically prescribed |
| Dosage (sports) |
100-200 mg per day |
| Effects |
Increases protein synthesis and nitrogen retention, promotes muscle strength and growth, enhances physical performance |
| Formula |
C27H42O4 |
| Half-life |
6-8 hours |
| Hepatotoxicity |
Possible mild hepatotoxicity |
| Lab Test |
Not standard in regular drug testing panels |
| Main action |
Anabolic |
| Side effects |
Limited research, but potential mild liver toxicity and influence on hormone levels |
| Storage conditions |
Store in a cool, dry place away from light |
| Substance class |
Brassinosteroid analog |
| Trade name |
Not available under a specific trade name |
| Use in sports |
Commonly used as a non-hormonal anabolic supplement |
| Water Retention |
No significant water retention reported |
| Manufacturer |
Biogenic pharma |
